COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis
NCT ID: NCT00113308
Last Updated: 2017-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
2208 participants
INTERVENTIONAL
2005-06-30
2006-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)
NCT02858492
A Study To Investigate The Effect Of 28 Days Of Dosing With GW856553 On Patients With Rheumatoid Arthritis
NCT00393146
An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis
NCT00383188
Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis
NCT01038674
A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis
NCT04985812
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GW406381
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Required a non-steroidal anti-inflammatory drug (NSAID) or COX-2 inhibitor for RA for at least 5 out of 7 days of each week for the 4 weeks prior to screening.
Exclusion Criteria
* Have an active stomach ulcer or history of any stomach tear or bleeding.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GSK Clinical Trials
Role: STUDY_DIRECTOR
GlaxoSmithKline
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GSK Investigational Site
Anniston, Alabama, United States
GSK Investigational Site
Birmingham, Alabama, United States
GSK Investigational Site
Birmingham, Alabama, United States
GSK Investigational Site
Huntsville, Alabama, United States
GSK Investigational Site
Montgomery, Alabama, United States
GSK Investigational Site
Montgomery, Alabama, United States
GSK Investigational Site
Glendale, Arizona, United States
GSK Investigational Site
Scottsdale, Arizona, United States
GSK Investigational Site
Tucson, Arizona, United States
GSK Investigational Site
Tucson, Arizona, United States
GSK Investigational Site
Anaheim, California, United States
GSK Investigational Site
Palm Desert, California, United States
GSK Investigational Site
San Diego, California, United States
GSK Investigational Site
San Diego, California, United States
GSK Investigational Site
San Diego, California, United States
GSK Investigational Site
Santa Monica, California, United States
GSK Investigational Site
Upland, California, United States
GSK Investigational Site
Colorado Springs, Colorado, United States
GSK Investigational Site
Bridgeport, Connecticut, United States
GSK Investigational Site
Danbury, Connecticut, United States
GSK Investigational Site
Hamden, Connecticut, United States
GSK Investigational Site
Trumbull, Connecticut, United States
GSK Investigational Site
Aventura, Florida, United States
GSK Investigational Site
Daytona Beach, Florida, United States
GSK Investigational Site
DeLand, Florida, United States
GSK Investigational Site
Dunedin, Florida, United States
GSK Investigational Site
Largo, Florida, United States
GSK Investigational Site
Miami, Florida, United States
GSK Investigational Site
Miami, Florida, United States
GSK Investigational Site
Ocala, Florida, United States
GSK Investigational Site
Orlando, Florida, United States
GSK Investigational Site
Orlando, Florida, United States
GSK Investigational Site
Palm Harbor, Florida, United States
GSK Investigational Site
Port Orange, Florida, United States
GSK Investigational Site
Stuart, Florida, United States
GSK Investigational Site
Tampa, Florida, United States
GSK Investigational Site
Trinity, Florida, United States
GSK Investigational Site
West Palm Beach, Florida, United States
GSK Investigational Site
Zephyrhills, Florida, United States
GSK Investigational Site
Atlanta, Georgia, United States
GSK Investigational Site
Gainsville, Georgia, United States
GSK Investigational Site
Roswell, Georgia, United States
GSK Investigational Site
Woodstock, Georgia, United States
GSK Investigational Site
Idaho Falls, Idaho, United States
GSK Investigational Site
Evanston, Illinois, United States
GSK Investigational Site
Morton Grove, Illinois, United States
GSK Investigational Site
Springfield, Illinois, United States
GSK Investigational Site
Evansville, Indiana, United States
GSK Investigational Site
Indianapolis, Indiana, United States
GSK Investigational Site
Indianapolis, Indiana, United States
GSK Investigational Site
Prairie Village, Kansas, United States
GSK Investigational Site
Wichita, Kansas, United States
GSK Investigational Site
Louisville, Kentucky, United States
GSK Investigational Site
Louisville, Kentucky, United States
GSK Investigational Site
Louisville, Kentucky, United States
GSK Investigational Site
New Orleans, Louisiana, United States
GSK Investigational Site
Slidell, Louisiana, United States
GSK Investigational Site
Wheaton, Maryland, United States
GSK Investigational Site
Fall River, Massachusetts, United States
GSK Investigational Site
Springfield, Massachusetts, United States
GSK Investigational Site
Kalamazoo, Michigan, United States
GSK Investigational Site
Lansing, Michigan, United States
GSK Investigational Site
St Louis, Missouri, United States
GSK Investigational Site
St Louis, Missouri, United States
GSK Investigational Site
Las Vegas, Nevada, United States
GSK Investigational Site
Las Vegas, Nevada, United States
GSK Investigational Site
Las Vegas, Nevada, United States
GSK Investigational Site
Reno, Nevada, United States
GSK Investigational Site
Dover, New Hampshire, United States
GSK Investigational Site
Berlin, New Jersey, United States
GSK Investigational Site
Mercerville, New Jersey, United States
GSK Investigational Site
Johnson City, New York, United States
GSK Investigational Site
Kingston, New York, United States
GSK Investigational Site
New York, New York, United States
GSK Investigational Site
North Massapequa, New York, United States
GSK Investigational Site
Rochester, New York, United States
GSK Investigational Site
Charlotte, North Carolina, United States
GSK Investigational Site
Gastonia, North Carolina, United States
GSK Investigational Site
Hickory, North Carolina, United States
GSK Investigational Site
Statesville, North Carolina, United States
GSK Investigational Site
Cleveland, Ohio, United States
GSK Investigational Site
Columbus, Ohio, United States
GSK Investigational Site
Concinnati, Ohio, United States
GSK Investigational Site
Mayfield Village, Ohio, United States
GSK Investigational Site
Oklahoma City, Oklahoma, United States
GSK Investigational Site
Tulsa, Oklahoma, United States
GSK Investigational Site
Tulsa, Oklahoma, United States
GSK Investigational Site
Medford, Oregon, United States
GSK Investigational Site
Duncansville, Pennsylvania, United States
GSK Investigational Site
Philadelphia, Pennsylvania, United States
GSK Investigational Site
Philadelphia, Pennsylvania, United States
GSK Investigational Site
West Reading, Pennsylvania, United States
GSK Investigational Site
Charleston, South Carolina, United States
GSK Investigational Site
Charleston, South Carolina, United States
GSK Investigational Site
Greer, South Carolina, United States
GSK Investigational Site
Hampton, South Carolina, United States
GSK Investigational Site
Murrells Inlet, South Carolina, United States
GSK Investigational Site
Memphis, Tennessee, United States
GSK Investigational Site
Austin, Texas, United States
GSK Investigational Site
Dallas, Texas, United States
GSK Investigational Site
San Antonio, Texas, United States
GSK Investigational Site
San Antonio, Texas, United States
GSK Investigational Site
Everett, Washington, United States
GSK Investigational Site
Vancouver, Washington, United States
GSK Investigational Site
Racine, Wisconsin, United States
GSK Investigational Site
Córdoba, Córdoba Province, Argentina
GSK Investigational Site
Córdoba, Córdoba Province, Argentina
GSK Investigational Site
Rosario, Santa Fe Province, Argentina
GSK Investigational Site
Buenos Aires, , Argentina
GSK Investigational Site
Buenos Aires, , Argentina
GSK Investigational Site
Buenos Aires, , Argentina
GSK Investigational Site
Buenos Aires, , Argentina
GSK Investigational Site
Buenos Aires, , Argentina
GSK Investigational Site
Córdoba, , Argentina
GSK Investigational Site
Quilmes, , Argentina
GSK Investigational Site
San Juan, , Argentina
GSK Investigational Site
San Miguel de Tucumán, , Argentina
GSK Investigational Site
Vienna, , Austria
GSK Investigational Site
Vienna, , Austria
GSK Investigational Site
Vienna, , Austria
GSK Investigational Site
Vienna, , Austria
GSK Investigational Site
Antwerp, , Belgium
GSK Investigational Site
Diepenbeek, , Belgium
GSK Investigational Site
Lommel, , Belgium
GSK Investigational Site
Mons, , Belgium
GSK Investigational Site
Pleven, , Bulgaria
GSK Investigational Site
Sofia, , Bulgaria
GSK Investigational Site
Sofia, , Bulgaria
GSK Investigational Site
Sofia, , Bulgaria
GSK Investigational Site
Varna, , Bulgaria
GSK Investigational Site
Edmonton, Alberta, Canada
GSK Investigational Site
Penticton, British Columbia, Canada
GSK Investigational Site
Victoria, British Columbia, Canada
GSK Investigational Site
Winnipeg, Manitoba, Canada
GSK Investigational Site
St. John's, Newfoundland and Labrador, Canada
GSK Investigational Site
Kitchener, Ontario, Canada
GSK Investigational Site
Mississauga, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Windsor, Ontario, Canada
GSK Investigational Site
Montreal, Quebec, Canada
GSK Investigational Site
Montreal, Quebec, Canada
GSK Investigational Site
Saint-Jérôme, Quebec, Canada
GSK Investigational Site
Sainte-Foy, Quebec, Canada
GSK Investigational Site
Trois-Rivières, Quebec, Canada
GSK Investigational Site
Saskatoon, Saskatchewan, Canada
GSK Investigational Site
Viña del Mar, Región de Valparaíso, Chile
GSK Investigational Site
Santiago, Región Metro de Santiago, Chile
GSK Investigational Site
Santiago, Región Metro de Santiago, Chile
GSK Investigational Site
San José, , Costa Rica
GSK Investigational Site
Aalborg, , Denmark
GSK Investigational Site
Ishøj, , Denmark
GSK Investigational Site
Odense C, , Denmark
GSK Investigational Site
Vejle, , Denmark
GSK Investigational Site
Helsinki, , Finland
GSK Investigational Site
Hyvinkää, , Finland
GSK Investigational Site
Kuopio, , Finland
GSK Investigational Site
Angers, , France
GSK Investigational Site
Cahors, , France
GSK Investigational Site
Chilly-Mazarin, , France
GSK Investigational Site
Corbeil-Essonnes, , France
GSK Investigational Site
Grenoble, , France
GSK Investigational Site
Lyon, , France
GSK Investigational Site
Paris, , France
GSK Investigational Site
Toulouse, , France
GSK Investigational Site
Tours, , France
GSK Investigational Site
Baden-Baden, Baden-Wurttemberg, Germany
GSK Investigational Site
Deggingen, Baden-Wurttemberg, Germany
GSK Investigational Site
Freiburg im Breisgau, Baden-Wurttemberg, Germany
GSK Investigational Site
Kippenheim, Baden-Wurttemberg, Germany
GSK Investigational Site
Stuttgart, Baden-Wurttemberg, Germany
GSK Investigational Site
Stuttgart, Baden-Wurttemberg, Germany
GSK Investigational Site
Weinheim, Baden-Wurttemberg, Germany
GSK Investigational Site
Bayreuth, Bavaria, Germany
GSK Investigational Site
Erlangen, Bavaria, Germany
GSK Investigational Site
Munich, Bavaria, Germany
GSK Investigational Site
Munich, Bavaria, Germany
GSK Investigational Site
Nuremberg, Bavaria, Germany
GSK Investigational Site
Passau, Bavaria, Germany
GSK Investigational Site
Hamburg, City state of Hamburg, Germany
GSK Investigational Site
Hamburg, City state of Hamburg, Germany
GSK Investigational Site
Hamburg, City state of Hamburg, Germany
GSK Investigational Site
Hüttenberg, Hesse, Germany
GSK Investigational Site
Wiesbaden, Hesse, Germany
GSK Investigational Site
Einbeck, Lower Saxony, Germany
GSK Investigational Site
Hanover, Lower Saxony, Germany
GSK Investigational Site
Hildesheim, Lower Saxony, Germany
GSK Investigational Site
Schwerin, Mecklenburg-Vorpommern, Germany
GSK Investigational Site
Aachen, North Rhine-Westphalia, Germany
GSK Investigational Site
Beckum, North Rhine-Westphalia, Germany
GSK Investigational Site
Bochum, North Rhine-Westphalia, Germany
GSK Investigational Site
Cologne, North Rhine-Westphalia, Germany
GSK Investigational Site
Essen, North Rhine-Westphalia, Germany
GSK Investigational Site
Goch, North Rhine-Westphalia, Germany
GSK Investigational Site
Hattingen, North Rhine-Westphalia, Germany
GSK Investigational Site
Münster, North Rhine-Westphalia, Germany
GSK Investigational Site
Witten, North Rhine-Westphalia, Germany
GSK Investigational Site
Rhaunen, Rhineland-Palatinate, Germany
GSK Investigational Site
Saarbrücken, Saarland, Germany
GSK Investigational Site
Chemnitz, Saxony, Germany
GSK Investigational Site
Delitzsch, Saxony, Germany
GSK Investigational Site
Dresden, Saxony, Germany
GSK Investigational Site
Freital, Saxony, Germany
GSK Investigational Site
Görlitz, Saxony, Germany
GSK Investigational Site
Leipzig, Saxony, Germany
GSK Investigational Site
Leipzig, Saxony, Germany
GSK Investigational Site
Schmiedeberg, Saxony, Germany
GSK Investigational Site
Wolmirstedt, Saxony-Anhalt, Germany
GSK Investigational Site
Elmshorn, Schleswig-Holstein, Germany
GSK Investigational Site
Lübeck, Schleswig-Holstein, Germany
GSK Investigational Site
Pinneberg, Schleswig-Holstein, Germany
GSK Investigational Site
Berlin, State of Berlin, Germany
GSK Investigational Site
Berlin, State of Berlin, Germany
GSK Investigational Site
Berlin, State of Berlin, Germany
GSK Investigational Site
Berlin, State of Berlin, Germany
GSK Investigational Site
Berlin, State of Berlin, Germany
GSK Investigational Site
Kavala, , Greece
GSK Investigational Site
Thessaloniki, , Greece
GSK Investigational Site
Thessaloniki, , Greece
GSK Investigational Site
Thessaloniki, , Greece
GSK Investigational Site
Budapest, , Hungary
GSK Investigational Site
Budapest, , Hungary
GSK Investigational Site
Budapest, , Hungary
GSK Investigational Site
Győr, , Hungary
GSK Investigational Site
Bangalore, , India
GSK Investigational Site
Bangalore, , India
GSK Investigational Site
Bangalore, , India
GSK Investigational Site
Chennai, , India
GSK Investigational Site
Hyderabad, , India
GSK Investigational Site
Hyderabad, Andhra Pradesh, , India
GSK Investigational Site
New Delhi, , India
GSK Investigational Site
Pune, , India
GSK Investigational Site
Dublin, , Ireland
GSK Investigational Site
Waterford, , Ireland
GSK Investigational Site
Pescara, Abruzzo, Italy
GSK Investigational Site
Benevento, Campania, Italy
GSK Investigational Site
Telese Terme (BN), Campania, Italy
GSK Investigational Site
Arenzano (GE), Liguria, Italy
GSK Investigational Site
Genoa, Liguria, Italy
GSK Investigational Site
Rozzano (MI), Lombardy, Italy
GSK Investigational Site
Pisa, Tuscany, Italy
GSK Investigational Site
Prato, Tuscany, Italy
GSK Investigational Site
Terni, Umbria, Italy
GSK Investigational Site
Montebelluna (TV), Veneto, Italy
GSK Investigational Site
Liepāja, , Latvia
GSK Investigational Site
Riga, , Latvia
GSK Investigational Site
Riga, , Latvia
GSK Investigational Site
Valmiera, , Latvia
GSK Investigational Site
Guadalajara, Jalisco, Mexico
GSK Investigational Site
Guadalajara, Jalisco, Mexico
GSK Investigational Site
Monterrey, Nuevo León, Mexico
GSK Investigational Site
Mexico City, , Mexico
GSK Investigational Site
México, , Mexico
GSK Investigational Site
México, , Mexico
GSK Investigational Site
Etten-Leur, , Netherlands
GSK Investigational Site
Gouda, , Netherlands
GSK Investigational Site
Heerlen, , Netherlands
GSK Investigational Site
Nijmegen, , Netherlands
GSK Investigational Site
The Hague, , Netherlands
GSK Investigational Site
Zwolle, , Netherlands
GSK Investigational Site
Auckland, , New Zealand
GSK Investigational Site
Auckland, , New Zealand
GSK Investigational Site
Christchurch, , New Zealand
GSK Investigational Site
Lower Hutt, , New Zealand
GSK Investigational Site
Rotorua, , New Zealand
GSK Investigational Site
Harstad, , Norway
GSK Investigational Site
Levanger, , Norway
GSK Investigational Site
Lillehammer, , Norway
GSK Investigational Site
Skien, , Norway
GSK Investigational Site
Tønsberg, , Norway
GSK Investigational Site
Lima, Lima Province, Peru
GSK Investigational Site
Callao, , Peru
GSK Investigational Site
Lima, , Peru
GSK Investigational Site
Lima, , Peru
GSK Investigational Site
Manila, , Philippines
GSK Investigational Site
Manila, , Philippines
GSK Investigational Site
Grudziądz, , Poland
GSK Investigational Site
Poznan, , Poland
GSK Investigational Site
Warsaw, , Poland
GSK Investigational Site
Wroclaw, , Poland
GSK Investigational Site
Wroclaw, , Poland
GSK Investigational Site
Caguas, Puerto Rico, Puerto Rico
GSK Investigational Site
Brasov, , Romania
GSK Investigational Site
Bucharest, , Romania
GSK Investigational Site
Bucharest, , Romania
GSK Investigational Site
Bucharest, , Romania
GSK Investigational Site
Moscow, , Russia
GSK Investigational Site
Moscow, , Russia
GSK Investigational Site
Moscow, , Russia
GSK Investigational Site
Moscow, , Russia
GSK Investigational Site
Ryazan, , Russia
GSK Investigational Site
Saint Petersburg, , Russia
GSK Investigational Site
Saratov, , Russia
GSK Investigational Site
Tula, , Russia
GSK Investigational Site
Yaroslavl, , Russia
GSK Investigational Site
Yaroslavl, , Russia
GSK Investigational Site
Yekaterinburg, , Russia
GSK Investigational Site
Korsten, Eastern Cape, South Africa
GSK Investigational Site
Boksburg, Gauteng, South Africa
GSK Investigational Site
Muckleneuk, Gauteng, South Africa
GSK Investigational Site
Parktown, Gauteng, South Africa
GSK Investigational Site
Cape Town, , South Africa
GSK Investigational Site
Durban, , South Africa
GSK Investigational Site
Erasmus Kloof, Pretoria, , South Africa
GSK Investigational Site
Kempton Park, , South Africa
GSK Investigational Site
Observatory, , South Africa
GSK Investigational Site
Pinetown, , South Africa
GSK Investigational Site
Anyang-si, , South Korea
GSK Investigational Site
Daegu, , South Korea
GSK Investigational Site
Seoul, , South Korea
GSK Investigational Site
Seoul, , South Korea
GSK Investigational Site
Seoul, , South Korea
GSK Investigational Site
Seoul, , South Korea
GSK Investigational Site
A Coruña, , Spain
GSK Investigational Site
Baracaldo/Vizcaya, , Spain
GSK Investigational Site
Barcelona, , Spain
GSK Investigational Site
Barcelona, , Spain
GSK Investigational Site
Barcelona, , Spain
GSK Investigational Site
Córdoba, , Spain
GSK Investigational Site
Granada, , Spain
GSK Investigational Site
Guadalajara, , Spain
GSK Investigational Site
Mérida (Badajoz), , Spain
GSK Investigational Site
Oviedo, , Spain
GSK Investigational Site
Pamplona, , Spain
GSK Investigational Site
San Sebastián, , Spain
GSK Investigational Site
Santiago de Compostela, , Spain
GSK Investigational Site
Seville, , Spain
GSK Investigational Site
Valencia, , Spain
GSK Investigational Site
Villajoyosa, , Spain
GSK Investigational Site
Kharkiv, , Ukraine
GSK Investigational Site
Kharkiv, , Ukraine
GSK Investigational Site
Kiev, , Ukraine
GSK Investigational Site
Kyiv, , Ukraine
GSK Investigational Site
Lviv, , Ukraine
GSK Investigational Site
Truro, Cornwall, United Kingdom
GSK Investigational Site
St Albans, Hertfordshire, United Kingdom
GSK Investigational Site
Manchester, Lancashire, United Kingdom
GSK Investigational Site
Metropolitan Borough of Wirral, Merseyside, United Kingdom
GSK Investigational Site
Ashford, Middlesex, United Kingdom
GSK Investigational Site
Northampton, Northamptonshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CXA30009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.